Ph.D. Candidate
College of Pharmacy, CHA University, Republic of Korea
Dong Wook Kang is a Ph.D. candidate in Biopharmaceutical Science at CHA University College of Pharmacy, South Korea. He received his Pharm.D. degree from CHA University in 2019 and is an RPh in South Korea. He is expected to complete his Ph.D. degree in August 2025. His research focuses on Model-Informed Drug Development (MIDD), which applies advanced pharmacometric approaches to bridge nonclinical studies and early clinical trials.
His specializations include differential equation-based modeling, population pharmacokinetic/pharmacodynamic (PK/PD) modeling, and physiologically-based pharmacokinetic (PBPK) modeling. As an experienced researcher, he has applied modeling approaches to nonclinical/clinical study design, first-in-human (FIH) dose selection, new dosage form development, drug repurposing, and drug-drug interaction assessment. He has expertise in modeling and simulation tools, including Phoenix WinNonlin, Monolix, PK-Sim, and Berkeley Madonna.
He has participated in numerous multidisciplinary projects and contributed to over 30 grant- and industry-funded research projects. His work spans from drug development to regulatory support across multiple therapeutic areas, including collaborations with governments and pharmaceutical companies. He has authored or co-authored over 20 peer-reviewed journal publications and received several awards for his presentations at scientific conferences.